BLOG / 🇺🇸 United States · · daily

USA Insider Trading Pulse — October 28, 2026

USA Insider Trading Pulse

By Gunpowder Editorial ·

50 high priority 50 total filings analysed

Executive Summary

The USA Insider Trading Pulse for 2026-10-28 covers 50 SEC Form 4 filings, overwhelmingly consisting of insider sales, purchases, equity awards, tax withholdings and gifts rather than M&A or financial-statement events.

Insider sentiment is mixed-to-negative in aggregate: roughly 20 filings are sales (dominated by a cluster of DRDGOLD LTD officers selling at a uniform $2.44 price after exercising conditional share awards, and sales by Roper, Travelers, State Street, Veracyte and Fifth Third insiders), while open-market purchases are concentrated in a handful of names including Accenture's Chair/CEO, Flagstar, XBiotech, Huntington preferred and Beacon Financial. The most material signal is Accenture's CEO Sweet Julie Spellman buying roughly $3.0M of Class A shares across two transactions at ~$245-246, which is a rare high-conviction open-market buy from a senior executive. Several sales were executed under Rule 10b5-1 plans (Verizon, Sturm Ruger, Castle Biosciences, Veracyte, Beta Bionics, Paylocity, State Street, Agios, Fiverr), which lowers the informational weight of those disposals. Because the filings are single-day Form 4 snapshots, period-over-period financial comparisons, forward guidance and capital allocation data are largely absent; conclusions here rest on transaction patterns, sizes and clustering rather than fundamentals.

Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →

Filing types in this digest: Form 4

Tracking the trend? Catch up on the prior USA Insider Trading Pulse digest from October 21, 2026.

Investment Signals (12)

  • Accenture plc ↓ (BULLISH)
    ▲

    Chair and CEO Sweet Julie Spellman bought ~12,200 Class A shares total (~$3.0M across 2,100 at $245.11 and 10,100 at $246.17), bringing holdings to 48,910; a senior open-market purchase of this size is a strong conviction signal

  • Flagstar Bank, N.A. (BULLISH)
    ▲

    Director Frank Alan L bought 10,000 common shares at $10.14 (~$101K), raising holdings to 76,463; director open-market buying at a bank name suggests confidence in valuation

  • XBiotech Inc. ↓ (BULLISH)
    ▲

    Director John Simard bought 368,524 shares at $1.93 (~$711K), now holding 4.19M shares; a meaningful director purchase in a small-cap biotech

  • Huntington Bancshares ↓ (BULLISH)
    ▲

    Director James D. Rollins III bought $254K across two series of non-cumulative preferred (10,000 Series I at $19.43 and 4,000 Series H at $14.86), a rare preferred-stock buy by a director

  • Beacon Financial Corp / LCNB Corp ↓ (BULLISH)
    ▲

    Directors Margaret Fitzgerald (329 shares, ~$10K) and Anne Krehbiel (1,000 shares, ~$19.8K) made small open-market purchases; modest in size but consistent with director confidence in regional banks

  • DRDGOLD LTD ↓ (BEARISH)
    ▲

    Eight insiders (CEO Pretorius, CFO Hooijer, COO Schoeman, Gouws, Kruger, Bornman, Moloto, Lindecke, Laas) all sold ordinary shares at a uniform $2.44 after exercising conditional share awards, a coordinated pattern that looks like a vesting/tax-driven liquidation rather than an opinion on value

  • Veracyte, Inc. ↓ (BEARISH)
    ▲

    Director Karin Eastham sold 14,850 shares at $50.00 (~$743K) and Director Jens Holstein sold 7,500 at $47-50; both exercised options first and sold at the same $50.00 limit price, suggesting limit-order profit-taking by directors

  • Travelers Companies ↓ (BEARISH)
    ▲

    EVP & Chief Tech & Ops Officer Mojgan Lefebvre sold 11,000 shares at $393.84 (~$4.33M) after exercising options struck at $139.83, a realized gain of roughly $2.8M and a full liquidation of the position (11,000 shares remaining)

  • Roper Technologies ↓ (BEARISH)
    ▲

    EVP, CLO & Secretary John Stipancich sold 3,500 shares at $449.04 (~$1.57M) after exercising at $275.69, locking in a ~63% gain on the options; holdings of 35,434 remain

  • State Street Corp ↓ (BEARISH)
    ▲

    EVP & Chief Risk Officer W. Bradford Hu sold 7,099 shares at $168.63 (~$1.2M) under a 10b5-1 plan, a routine diversification sale that carries limited signal

  • Fifth Third Bancorp ↓ (BEARISH)
    ▲

    EVP & CIO Jude Schramm executed 26 small-lot sales totaling ~3,032 shares near $53, leaving 121,460 shares; a steady distribution pattern rather than a single conviction exit

  • Dime Community Bancshares ↓ (BEARISH)
    ▲

    CTO/Ops Officer Michael Fegan sold 2,355 shares at $41.81 (~$98.5K) while Director Joseph Perry sold 3,000 preferred shares at $16.88 (~$50.6K); both are modest sales from bank insiders

Risk Flags (9)

  • DRDGOLD LTD / Insider Liquidation Cluster↓ [HIGH RISK]
    ▼

    Nine officers including the CEO, CFO and COO sold ~470,000 ordinary shares in aggregate at a single $2.44 price after exercising conditional awards; the coordinated timing across the executive team is a concentrated insider-selling risk signal

  • Verizon Communications↓ [MEDIUM RISK]
    ▼

    EVP and Group CEO-VZ Business Kyle Malady sold 1,100 shares at $43.00 (~$47K) leaving 98,866 shares; small in dollar terms but a senior divisional executive selling, mitigated by a 10b5-1 plan

  • Travelers Companies↓ [HIGH RISK]
    ▼

    Full liquidation of an option-exercised position by EVP Mojgan Lefebvre (11,000 sold, 0 retained) worth ~$4.33M; a complete exit by a senior technology executive can be read as reduced confidence in near-term upside

  • Washington Trust Bancorp↓ [MEDIUM RISK]
    ▼

    Director Edwin Santos sold 1,200 shares at $39.25 (~$47K), cutting holdings to 9,110, an outright reduction by a director at a regional bank

  • Veracyte, Inc.↓ [MEDIUM RISK]
    ▼

    Two directors (Eastham and Holstein) sold a combined ~22,350 shares at $47-50 totaling ~$1.1M, with Eastham exiting to 10,247 shares; repeated director selling at the same $50 limit suggests valuation-based distribution

  • Paylocity Holding Corp↓ [MEDIUM RISK]
    ▼

    Director Steven Sarowitz sold ~8,300 shares across three tranches ($170-173, ~$1.4M total) under a 10b5-1 plan; a large holder with 4.35M shares still held, but sustained selling by a major director warrants monitoring

  • Fifth Third Bancorp↓ [MEDIUM RISK]
    ▼

    26 separate sale transactions by the CIO totaling ~3,000 shares indicates systematic, ongoing distribution rather than a discrete event; repeated disposals from one senior officer raise the cumulative-selling concern

  • Amber International Holding Ltd↓ [HIGH RISK]
    ▼

    CEO Wu Yuao disposed of 309.8M Class A shares across 15 transactions while acquiring 69.6M and 19.5M shares in other transactions; the gross disposal far exceeds the reported holdings of 2.29M, so the filing structure (likely reclassification or nominee/entity transfers) needs verification before drawing conclusions

  • Sturm Ruger & Co↓ [LOW RISK]
    ▼

    VP of New Product Development Michael Wilson sold 628 shares at $45.47 under a 10b5-1 plan; small size, but it is the only sale in the set from a product-development officer at a company with no other insider signal

Opportunities (8)

  • Accenture plc / CEO Open-Market Buy↓ (OPPORTUNITY)
    ◆

    Chair and CEO buying ~$3.0M of stock at ~$245 is a strong alignment signal from the company's most senior executive; the purchase price is a reference point for monitoring upside if the stock re-rates

  • Accenture plc / Director Confirmation↓ (OPPORTUNITY)
    ◆

    Director Paula Price bought 800 shares at $249.81 (~$200K), a second independent insider purchase on the same stock in the same window, which strengthens the cluster-buy thesis

  • Huntington Bancshares / Preferred Stock Buy↓ (OPPORTUNITY)
    ◆

    Director Rollins' purchase of two preferred series (5.70% Series I and 4.50% Series H) at discounts to par ($19.43 and $14.86) is an income-oriented entry; combined with multiple director equity awards (Diaz-Granados, Shea, Neu, Sit, Crane), the board appears engaged

  • XBiotech Inc. / Director Accumulation↓ (OPPORTUNITY)
    ◆

    Director Simard's ~$711K purchase at $1.93 raises his stake to 4.19M shares; insider accumulation at a sub-$2 price in a biotech with an active pipeline could mark a valuation floor for patient capital

  • Flagstar Bank / Insider Accumulation↓ (OPPORTUNITY)
    ◆

    Director Alan Frank's $101K purchase at $10.14 follows what appears to be a sustained board holding, offering a regional-bank value entry point supported by insider buying

  • Beacon Financial & LCNB Corp / Director Entry Points (OPPORTUNITY)
    ◆

    Small director purchases at Beacon ($30.77) and LCNB ($19.79) are low-dollar but consistent with board confidence in community bank valuations; worth tracking for follow-on buying

  • Fulgent Genetics / Executive Retention↓ (OPPORTUNITY)
    ◆

    Chief Scientific Officer Gao Hanlin (984,472 shares held) and President/COO Xie Jian (355,563 shares) had only tax withholding on vesting, leaving their large retained stakes intact; a sign of management ownership without selling pressure

  • Intellia Therapeutics / Equity Award Signal↓ (OPPORTUNITY)
    ◆

    CMO Jing Marantz received 199,822 shares and 275,061 options in a single grant, a large retention package that aligns a clinical executive with long-term value creation

Sector Themes (5)

  • Mining Insider Liquidation at Uniform Price (THEME)
    ◆

    All nine DRDGOLD filings report sales at exactly $2.44, indicating a single block/fixed-price execution across the officer group; the pattern concentrates selling in one issuer and should be read as a coordinated, tax-linked liquidity event rather than a broad sector signal

  • Regional Banks: Mixed Insider Flow (THEME)
    ◆

    Across Huntington, Fifth Third, Washington Trust, Dime Community, Flagstar, Beacon, LCNB and FS Bancorp, insider activity splits between director buying (Flagstar, Beacon, LCNB, Huntington preferred) and executive/director selling (Fifth Third, Washington Trust, Dime); with ~50% of bank-filing transactions being sales, the group shows no clear directional consensus

  • Director Equity Awards Dominate Non-Trading Activity (THEME)
    ◆

    At least eight filings (Huntington x5, Stock Yards, Lightwave Logic, Vir Biotechnology, Newell Brands COO) report awarded shares or RSUs rather than market transactions, indicating routine board and executive compensation flow with limited directional information

  • Rule 10b5-1 Plans Shape Sale Activity (THEME)
    ◆

    Roughly ten of the sales (Verizon, Sturm Ruger, Castle Biosciences, Veracyte, Beta Bionics, Paylocity, State Street, Agios, Fiverr and others) were executed under pre-arranged 10b5-1 plans, so the sales should be weighted lower than discretionary sales when assessing insider sentiment

  • Life Sciences Option-Driven Selling (THEME)
    ◆

    Biotech and diagnostics insiders (Veracyte, Agios, Castle Biosciences, Beta Bionics, Intellia, XBiotech) show a pattern of exercising options at low strikes ($25-35) and selling at $20-50, producing realized gains that are typical of post-vesting diversification rather than negative fundamental views

Watch List (8)

  • Amber International Holding Ltd↓
    👁

    309.8M-share disposal by CEO Wu Yuao across 15 transactions does not reconcile with the 2.29M shares reported as held after; verify the filing structure and any change-of-control or reorganization event before the next Form 4 or 13D/G amendment [date not provided]

  • DRDGOLD LTD↓
    👁

    Watch for further officer sales if conditional awards continue to vest, and for any company statement explaining the uniform $2.44 execution price; the executive group's concentrated liquidation is the single largest insider-selling cluster in this set [date not provided]

  • Accenture plc↓
    👁

    Monitor whether the CEO's ~$3.0M purchase is followed by additional insider buys or a company response on capital return at current levels, as Accenture is the only large-cap name in the set with a senior-executive open-market purchase [date not provided]

  • Veracyte, Inc.↓
    👁

    Track whether the directors' sales at $50.00 continue; the repeated limit-price pattern across two directors suggests a price target that may cap upside or signal further distribution [date not provided]

  • Travelers Companies↓
    👁

    Follow up on whether the full liquidation by EVP Mojgan Lefebvre is followed by additional insider exits in the technology and operations leadership, which would strengthen the bearish read [date not provided]

  • Huntington Bancshares↓
    👁

    Monitor for further director purchases of preferred series after Rollins' buys, and whether the multiple director equity awards on the same date reflect a board-wide compensation event [date not provided]

  • XBiotech Inc.↓
    👁

    Track whether Director Simard continues accumulating below $2.00, which would signal sustained insider conviction in an otherwise thinly followed biotech [date not provided]

  • Paylocity Holding Corp↓
    👁

    Watch Director Sarowitz's ongoing 10b5-1 sales (now ~4.35M shares retained) for any acceleration beyond the plan schedule, which would increase the bearish weight of the trading pattern [date not provided]

Filing Analyses (50)
Accenture plc 4 positive materiality 8/10

28-10-2026

Chair and CEO Sweet Julie Spellman bought 10,100 Class A ordinary shares at $246.17 (~$2.49M). Sweet Julie Spellman holds 48,910 shares after the transaction.

  • · Chair and CEO Sweet Julie Spellman bought 2,100 Class A ordinary shares at $245.11 (~$515K)
  • · Chair and CEO Sweet Julie Spellman bought 10,100 Class A ordinary shares at $246.17 (~$2.49M)
Accenture plc 4 positive materiality 5/10

28-10-2026

Director Price Paula A bought 800 Class A ordinary shares at $249.81 (~$200K). Price Paula A holds 9,361 shares after the transaction.

  • · Director Price Paula A bought 800 Class A ordinary shares at $249.81 (~$200K)
Amber International Holding Ltd 4 neutral materiality 6/10

28-10-2026

Chief Executive Officer Wu Yuao disposed of 309,834,748 Class A ordinary shares, par value $0.001 per share. 15 transactions reported in total. Wu Yuao holds 2,287,892 shares after the transaction.

  • · Chief Executive Officer Wu Yuao disposed of 309,834,748 Class A ordinary shares, par value $0.001 per share
  • · Chief Executive Officer Wu Yuao acquired 69,552,266 Class A ordinary shares, par value $0.001 per share
  • · Chief Executive Officer Wu Yuao acquired 19,458,931 Class A ordinary shares, par value $0.001 per share
  • · Chief Executive Officer Wu Yuao acquired 6,698,479 Class A ordinary shares, par value $0.001 per share
  • · Chief Executive Officer Wu Yuao acquired 4,620,646 Class A ordinary shares, par value $0.001 per share
  • · Chief Executive Officer Wu Yuao disposed of 11,729,691 Class A ordinary shares, par value $0.001 per share
  • · Chief Executive Officer Wu Yuao disposed of 6,225,342 Class A ordinary shares, par value $0.001 per share
  • · Chief Executive Officer Wu Yuao disposed of 18,147,222 Class A ordinary shares, par value $0.001 per share
Beacon Financial Corp 4 positive materiality 3/10

28-10-2026

Director Fitzgerald Margaret Boles bought 329 Common Stock at $30.77 (~$10.1K). Fitzgerald Margaret Boles holds 18,909 shares after the transaction.

  • · Director Fitzgerald Margaret Boles bought 329 Common Stock at $30.77 (~$10.1K)
Dime Community Bancshares, Inc. /NY/ 4 negative materiality 3/10

28-10-2026

Chief Technology & Ops Officer Fegan Michael sold 2,355 Common Stock at $41.81 (~$98.5K). Fegan Michael holds 25,618 shares after the transaction.

  • · Chief Technology & Ops Officer Fegan Michael sold 2,355 Common Stock at $41.81 (~$98.5K)
CENTRAL SECURITIES CORP 4 neutral materiality 2/10

28-10-2026

10% owner ENDEAVOR FOUNDATION, INC. gifted 18,000 Common Stock. ENDEAVOR FOUNDATION, INC. holds 9,432,785 shares after the transaction.

  • · 10% owner ENDEAVOR FOUNDATION, INC. gifted 18,000 Common Stock
TAL Education Group 4 neutral materiality 5/10

28-10-2026

Director ZHANG KAIFU had withheld for taxes 4,248 American Depositary Shares at $10.24 (~$43.5K). 4 transactions reported in total. ZHANG KAIFU holds 64,892 shares after the transaction.

  • · Director ZHANG KAIFU exercised/converted 15,300 American Depositary Shares
  • · Director ZHANG KAIFU had withheld for taxes 4,248 American Depositary Shares at $10.24 (~$43.5K)
  • · Director ZHANG KAIFU exercised/converted 15,300 Restricted Stock Units (RSU)
  • · Director ZHANG KAIFU was awarded 35,307 Stock Option (Right to Buy)
RADWARE LTD 4 neutral materiality 6/10

28-10-2026

Chief Operating Officer Malka Gabriel was awarded 11,000 Ordinary shares. Malka Gabriel holds 58,922 shares after the transaction.

  • · Chief Operating Officer Malka Gabriel was awarded 11,000 Ordinary shares
LCNB CORP 4 positive materiality 3/10

28-10-2026

Director Krehbiel Anne E bought 1,000 LCNB Corp Common Stock at $19.79 (~$19.8K). Krehbiel Anne E holds 13,122 shares after the transaction.

  • · Director Krehbiel Anne E bought 1,000 LCNB Corp Common Stock at $19.79 (~$19.8K)
FS Bancorp, Inc. 4 neutral materiality 6/10

28-10-2026

Chief Home Lending, EVP COSTA DONN C had withheld for taxes 36,800 Common Stock at $43.77 (~$1.61M). COSTA DONN C holds 76,172 shares after the transaction.

  • · Chief Home Lending, EVP COSTA DONN C exercised/converted 36,800 Common Stock at $29.30 (~$1.08M)
  • · Chief Home Lending, EVP COSTA DONN C had withheld for taxes 36,800 Common Stock at $43.77 (~$1.61M)
  • · Chief Home Lending, EVP COSTA DONN C exercised/converted 36,800 Stock Option (Right to Buy)
DRDGOLD LTD 4 negative materiality 7/10

28-10-2026

Chief Financial Officer Hooijer Henriette sold 22,687 Ordinary Shares at $2.44 (~$55.4K). 4 transactions reported in total. Hooijer Henriette holds 199,827 shares after the transaction.

  • · Chief Financial Officer Hooijer Henriette exercised/converted 50,415 Ordinary Shares
  • · Chief Financial Officer Hooijer Henriette sold 22,687 Ordinary Shares at $2.44 (~$55.4K)
  • · Chief Financial Officer Hooijer Henriette exercised/converted 50,415 Conditional Share Awards
  • · Chief Financial Officer Hooijer Henriette disposed of 33,610 Conditional Share Awards
DRDGOLD LTD 4 negative materiality 7/10

28-10-2026

Chief Executive Officer Pretorius Daniel sold 117,980 Ordinary Shares at $2.44 (~$288K). 4 transactions reported in total. Pretorius Daniel holds 1,144,012 shares after the transaction.

  • · Chief Executive Officer Pretorius Daniel exercised/converted 262,176 Ordinary Shares
  • · Chief Executive Officer Pretorius Daniel sold 117,980 Ordinary Shares at $2.44 (~$288K)
  • · Chief Executive Officer Pretorius Daniel exercised/converted 262,176 Conditional Share Awards
  • · Chief Executive Officer Pretorius Daniel disposed of 174,783 Conditional Share Awards
DRDGOLD LTD 4 negative materiality 6/10

28-10-2026

Head of Prod., Dir. of Ergo Gouws Henry sold 89,160 Ordinary Shares at $2.44 (~$218K). 4 transactions reported in total. Gouws Henry holds 3,050 shares after the transaction.

  • · Head of Prod., Dir. of Ergo Gouws Henry exercised/converted 89,160 Ordinary Shares
  • · Head of Prod., Dir. of Ergo Gouws Henry sold 89,160 Ordinary Shares at $2.44 (~$218K)
  • · Head of Prod., Dir. of Ergo Gouws Henry exercised/converted 89,160 Conditional Share Awards
  • · Head of Prod., Dir. of Ergo Gouws Henry disposed of 59,440 Conditional Share Awards
FIDELITY D & D BANCORP INC 4 neutral materiality 3/10

28-10-2026

Director Silverman Alan gifted 300 common stock. Silverman Alan holds 24,180.7899 shares after the transaction.

  • · Director Silverman Alan gifted 300 common stock
DRDGOLD LTD 4 negative materiality 6/10

28-10-2026

Head of Technical Services Kruger Kevin sold 73,830 Ordinary Shares at $2.44 (~$180K). 4 transactions reported in total. Kruger Kevin holds 9,240 shares after the transaction.

  • · Head of Technical Services Kruger Kevin exercised/converted 73,830 Ordinary Shares
  • · Head of Technical Services Kruger Kevin sold 73,830 Ordinary Shares at $2.44 (~$180K)
  • · Head of Technical Services Kruger Kevin exercised/converted 73,830 Conditional Share Awards
  • · Head of Technical Services Kruger Kevin disposed of 49,219 Conditional Share Awards
VERIZON COMMUNICATIONS INC 4 negative materiality 3/10

28-10-2026

EVP and Group CEO-VZ Business Malady Kyle sold 1,100 Common Stock at $43.00 (~$47.3K). Malady Kyle holds 98,866 shares after the transaction. Trades executed under a Rule 10b5-1 plan.

  • · EVP and Group CEO-VZ Business Malady Kyle sold 1,100 Common Stock at $43.00 (~$47.3K)
DRDGOLD LTD 4 negative materiality 4/10

28-10-2026

Financial Manager Ergo Ops. Bornman Ryno sold 8,388 Ordinary Shares at $2.44 (~$20.5K). 4 transactions reported in total. Bornman Ryno holds 16,959 shares after the transaction.

  • · Financial Manager Ergo Ops. Bornman Ryno exercised/converted 18,639 Ordinary Shares
  • · Financial Manager Ergo Ops. Bornman Ryno sold 8,388 Ordinary Shares at $2.44 (~$20.5K)
  • · Financial Manager Ergo Ops. Bornman Ryno exercised/converted 18,639 Conditional Share Awards
  • · Financial Manager Ergo Ops. Bornman Ryno disposed of 12,425 Conditional Share Awards
DRDGOLD LTD 4 negative materiality 6/10

28-10-2026

General Manager FWGR Ops. Moloto Kgabo sold 21,999 Ordinary Shares at $2.44 (~$53.7K). 4 transactions reported in total. Moloto Kgabo holds 21,999 shares after the transaction.

  • · General Manager FWGR Ops. Moloto Kgabo exercised/converted 21,999 Ordinary Shares
  • · General Manager FWGR Ops. Moloto Kgabo sold 21,999 Ordinary Shares at $2.44 (~$53.7K)
  • · General Manager FWGR Ops. Moloto Kgabo exercised/converted 21,999 Conditional Share Awards
  • · General Manager FWGR Ops. Moloto Kgabo disposed of 14,665 Conditional Share Awards
DRDGOLD LTD 4 negative materiality 6/10

28-10-2026

General Manager Ergo Ops. Lindecke Dean sold 48,948 Ordinary Shares at $2.44 (~$119K). 4 transactions reported in total. Lindecke Dean holds 48,948 shares after the transaction.

  • · General Manager Ergo Ops. Lindecke Dean exercised/converted 48,948 Ordinary Shares
  • · General Manager Ergo Ops. Lindecke Dean sold 48,948 Ordinary Shares at $2.44 (~$119K)
  • · General Manager Ergo Ops. Lindecke Dean exercised/converted 48,948 Conditional Share Awards
  • · General Manager Ergo Ops. Lindecke Dean disposed of 32,631 Conditional Share Awards
DRDGOLD LTD 4 negative materiality 7/10

28-10-2026

Chief Operating Officer Schoeman Jacobus sold 94,575 Ordinary Shares at $2.44 (~$231K). 4 transactions reported in total. Schoeman Jacobus holds 70,000 shares after the transaction.

  • · Chief Operating Officer Schoeman Jacobus exercised/converted 139,575 Ordinary Shares
  • · Chief Operating Officer Schoeman Jacobus sold 94,575 Ordinary Shares at $2.44 (~$231K)
  • · Chief Operating Officer Schoeman Jacobus exercised/converted 139,575 Conditional Share Awards
  • · Chief Operating Officer Schoeman Jacobus disposed of 93,049 Conditional Share Awards
DRDGOLD LTD 4 negative materiality 6/10

28-10-2026

Financial Manager FWGR Ops. Laas Lihan sold 14,787 Ordinary Shares at $2.44 (~$36.1K). 4 transactions reported in total. Laas Lihan holds 14,787 shares after the transaction.

  • · Financial Manager FWGR Ops. Laas Lihan exercised/converted 14,787 Ordinary Shares
  • · Financial Manager FWGR Ops. Laas Lihan sold 14,787 Ordinary Shares at $2.44 (~$36.1K)
  • · Financial Manager FWGR Ops. Laas Lihan exercised/converted 14,787 Conditional Share Awards
  • · Financial Manager FWGR Ops. Laas Lihan disposed of 9,857 Conditional Share Awards
WASHINGTON TRUST BANCORP INC 4 negative materiality 4/10

28-10-2026

Director Santos Edwin J sold 1,200 Common Stock at $39.25 (~$47.1K). Santos Edwin J holds 9,110 shares after the transaction.

  • · Director Santos Edwin J sold 1,200 Common Stock at $39.25 (~$47.1K)
Vir Biotechnology, Inc. 4 neutral materiality 5/10

28-10-2026

Director Topalian Suzanne Louise was awarded 8,000 Common Stock. 4 transactions reported in total. Topalian Suzanne Louise holds 12,731 shares after the transaction.

  • · Director Topalian Suzanne Louise was awarded 8,000 Common Stock
  • · Director Topalian Suzanne Louise was awarded 4,731 Common Stock
  • · Director Topalian Suzanne Louise was awarded 16,000 Stock Option (Right to Buy)
  • · Director Topalian Suzanne Louise was awarded 9,462 Stock Option (Right to Buy)
Dime Community Bancshares, Inc. /NY/ 4 negative materiality 5/10

28-10-2026

Director Perry Joseph sold 3,000 Preferred Stock, Series A at $16.88 (~$50.6K). Perry Joseph holds 54,806 shares after the transaction.

  • · Director Perry Joseph sold 3,000 Preferred Stock, Series A at $16.88 (~$50.6K)
  • · Director Perry Joseph gifted 194 The Joseph John Perry Rev. Trust
FLAGSTAR BANK, NATIONAL ASSOCIATION 4 positive materiality 6/10

28-10-2026

Director Frank Alan L bought 10,000 Common Stock at $10.14 (~$101K). Frank Alan L holds 76,463 shares after the transaction.

  • · Director Frank Alan L bought 10,000 Common Stock at $10.14 (~$101K)
XBiotech Inc. 4 positive materiality 4/10

28-10-2026

Director SIMARD JOHN bought 368,524 Common Stock at $1.93 (~$711K). SIMARD JOHN holds 4,191,690 shares after the transaction.

  • · Director SIMARD JOHN bought 368,524 Common Stock at $1.93 (~$711K)
STURM RUGER & CO INC 4 negative materiality 4/10

28-10-2026

VP of New Product Development Wilson Michael W sold 628 Common Stock at $45.47 (~$28.6K). Trades executed under a Rule 10b5-1 plan.

  • · VP of New Product Development Wilson Michael W sold 628 Common Stock at $45.47 (~$28.6K)
CASTLE BIOSCIENCES INC 4 negative materiality 5/10

28-10-2026

Chief Commercial Officer Juvenal Tobin W sold 3,288 Common Stock at $33.08 (~$109K). Juvenal Tobin W holds 45,431 shares after the transaction. Trades executed under a Rule 10b5-1 plan.

  • · Chief Commercial Officer Juvenal Tobin W sold 3,288 Common Stock at $33.08 (~$109K)
ROPER TECHNOLOGIES INC 4 negative materiality 6/10

28-10-2026

EVP, Chief Legal Officer & Sec Stipancich John K sold 3,500 Common Stock at $449.04 (~$1.57M). 4 transactions reported in total. Stipancich John K holds 35,434 shares after the transaction.

  • · EVP, Chief Legal Officer & Sec Stipancich John K gifted 200 Common Stock
  • · EVP, Chief Legal Officer & Sec Stipancich John K exercised/converted 3,500 Common Stock at $275.69 (~$965K)
  • · EVP, Chief Legal Officer & Sec Stipancich John K sold 3,500 Common Stock at $449.04 (~$1.57M)
  • · EVP, Chief Legal Officer & Sec Stipancich John K exercised/converted 3,500 Employee Stock Options (right to buy) at $275.69 (~$965K)
Intellia Therapeutics, Inc. 4 neutral materiality 5/10

28-10-2026

EVP, Chief Medical Officer Marantz Jing L. was awarded 199,822 Common Stock. Marantz Jing L. holds 199,822 shares after the transaction.

  • · EVP, Chief Medical Officer Marantz Jing L. was awarded 199,822 Common Stock
  • · EVP, Chief Medical Officer Marantz Jing L. was awarded 275,061 Stock Option (right to buy)
NEWELL BRANDS INC. 4 neutral materiality 5/10

28-10-2026

Chief Operating Officer Beade Guillermo Hugo was awarded 129,390 Restricted Stock Units.

  • · Chief Operating Officer Beade Guillermo Hugo was awarded 129,390 Restricted Stock Units
FIFTH THIRD BANCORP 4 negative materiality 4/10

28-10-2026

EVP & CIO Schramm Jude sold 3,032 Common Stock at $53.18 (~$161K). 26 transactions reported in total. Schramm Jude holds 121,460 shares after the transaction.

  • · EVP & CIO Schramm Jude sold 800 Common Stock at $53.04 (~$42.4K)
  • · EVP & CIO Schramm Jude sold 400 Common Stock at $53.05 (~$21.2K)
  • · EVP & CIO Schramm Jude sold 400 Common Stock at $53.06 (~$21.2K)
  • · EVP & CIO Schramm Jude sold 400 Common Stock at $53.07 (~$21.2K)
  • · EVP & CIO Schramm Jude sold 300 Common Stock at $53.08 (~$15.9K)
  • · EVP & CIO Schramm Jude sold 1,691 Common Stock at $53.09 (~$89.8K)
  • · EVP & CIO Schramm Jude sold 900 Common Stock at $53.10 (~$47.8K)
  • · EVP & CIO Schramm Jude sold 400 Common Stock at $53.12 (~$21.2K)
VERACYTE, INC. 4 negative materiality 5/10

28-10-2026

Director Holstein Jens sold 7,500 Common Stock at $50.00 (~$375K). 6 transactions reported in total. Holstein Jens holds 27,471 shares after the transaction. Trades executed under a Rule 10b5-1 plan.

  • · Director Holstein Jens exercised/converted 7,500 Common Stock at $35.30 (~$265K)
  • · Director Holstein Jens sold 7,500 Common Stock at $47.00 (~$353K)
  • · Director Holstein Jens exercised/converted 7,500 Common Stock at $35.30 (~$265K)
  • · Director Holstein Jens sold 7,500 Common Stock at $50.00 (~$375K)
  • · Director Holstein Jens exercised/converted 7,500 Stock Option (right to buy)
  • · Director Holstein Jens exercised/converted 7,500 Stock Option (right to buy)
Beta Bionics, Inc. 4 negative materiality 3/10

28-10-2026

Chief Commercial Officer Hopman Mark sold 821 Common Stock at $20.00 (~$16.4K). Hopman Mark holds 54,513 shares after the transaction. Trades executed under a Rule 10b5-1 plan.

  • · Chief Commercial Officer Hopman Mark sold 821 Common Stock at $20.00 (~$16.4K)
TRAVELERS COMPANIES, INC. 4 negative materiality 8/10

28-10-2026

EVP & Chief Tech & Ops Officer Lefebvre Mojgan M sold 11,000 Common Stock at $393.84 (~$4.33M). Lefebvre Mojgan M holds 11,000 shares after the transaction.

  • · EVP & Chief Tech & Ops Officer Lefebvre Mojgan M exercised/converted 11,000 Common Stock at $139.83 (~$1.54M)
  • · EVP & Chief Tech & Ops Officer Lefebvre Mojgan M sold 11,000 Common Stock at $393.84 (~$4.33M)
  • · EVP & Chief Tech & Ops Officer Lefebvre Mojgan M exercised/converted 11,000 Stock Options (Right to Buy)
Paylocity Holding Corp 4 negative materiality 4/10

28-10-2026

Director Sarowitz Steven I sold 4,500 Common Stock, par value $0.001 at $170.44 (~$767K). 5 transactions reported in total. Sarowitz Steven I holds 4,354,869 shares after the transaction. Trades executed under a Rule 10b5-1 plan.

  • · Director Sarowitz Steven I sold 4,500 Common Stock, par value $0.001 at $170.44 (~$767K)
  • · Director Sarowitz Steven I sold 2,600 Common Stock, par value $0.001 at $171.69 (~$446K)
  • · Director Sarowitz Steven I sold 1,200 Common Stock, par value $0.001 at $172.50 (~$207K)
  • · Director Sarowitz Steven I sold 500 Common Stock, par value $0.001 at $173.54 (~$86.8K)
  • · Director Sarowitz Steven I sold 100 Common Stock, par value $0.001 at $175.22 (~$17.5K)
STATE STREET CORP 4 negative materiality 6/10

28-10-2026

EVP and Chief Risk Officer Hu W. Bradford sold 7,099 Common Stock at $168.63 (~$1.2M). Hu W. Bradford holds 42,695 shares after the transaction. Trades executed under a Rule 10b5-1 plan.

  • · EVP and Chief Risk Officer Hu W. Bradford sold 7,099 Common Stock at $168.63 (~$1.2M)
VERACYTE, INC. 4 negative materiality 7/10

28-10-2026

Director EASTHAM KARIN sold 14,850 Common Stock at $50.00 (~$743K). EASTHAM KARIN holds 10,247 shares after the transaction. Trades executed under a Rule 10b5-1 plan.

  • · Director EASTHAM KARIN exercised/converted 10,000 Common Stock at $27.01 (~$270K)
  • · Director EASTHAM KARIN sold 14,850 Common Stock at $50.00 (~$743K)
  • · Director EASTHAM KARIN exercised/converted 10,000 Stock Option (right to buy)
HUNTINGTON BANCSHARES INC /MD/ 4 neutral materiality 3/10

28-10-2026

Director Diaz-Granados Rafael was awarded 2,729.88 Common Stock. Diaz-Granados Rafael holds 40,414.259 shares after the transaction.

  • · Director Diaz-Granados Rafael was awarded 2,729.88 Common Stock
HUNTINGTON BANCSHARES INC /MD/ 4 neutral materiality 3/10

28-10-2026

Director Shea Teresa H was awarded 949.523 Common Stock. Shea Teresa H holds 12,885.04 shares after the transaction.

  • · Director Shea Teresa H was awarded 949.523 Common Stock
HUNTINGTON BANCSHARES INC /MD/ 4 neutral materiality 3/10

28-10-2026

Director NEU RICHARD W was awarded 3,252.117 Common Stock. NEU RICHARD W holds 123,673.235 shares after the transaction.

  • · Director NEU RICHARD W was awarded 3,252.117 Common Stock
HUNTINGTON BANCSHARES INC /MD/ 4 neutral materiality 3/10

28-10-2026

Director Sit Roger J was awarded 1,978.174 Common Stock. Sit Roger J holds 52,885.888 shares after the transaction.

  • · Director Sit Roger J was awarded 1,978.174 Common Stock
AGIOS PHARMACEUTICALS, INC. 4 negative materiality 5/10

28-10-2026

Chief Medical Officer Gheuens Sarah sold 7,866 Common stock at $37.69 (~$296K). Gheuens Sarah holds 54,645 shares after the transaction. Trades executed under a Rule 10b5-1 plan.

  • · Chief Medical Officer Gheuens Sarah exercised/converted 7,866 Common stock at $25.01 (~$197K)
  • · Chief Medical Officer Gheuens Sarah sold 7,866 Common stock at $37.69 (~$296K)
  • · Chief Medical Officer Gheuens Sarah exercised/converted 7,866 Stock options (right to buy)
Stock Yards Bancorp, Inc. 4 neutral materiality 3/10

28-10-2026

Director Hardy David L. was awarded 96 Common Stock at $79.19 (~$7.6K). Hardy David L. holds 1,122 shares after the transaction.

  • · Director Hardy David L. was awarded 96 Common Stock at $79.19 (~$7.6K)
Fiverr International Ltd. 4 negative materiality 2/10

28-10-2026

Director Garten Yael sold 1,138 Ordinary Shares at $8.30 (~$9.45K). Garten Yael holds 42,352 shares after the transaction. Trades executed under a Rule 10b5-1 plan.

  • · Director Garten Yael sold 1,138 Ordinary Shares at $8.30 (~$9.45K)
Lightwave Logic, Inc. 4 neutral materiality 4/10

28-10-2026

Director KENNEDY EDWARD H was awarded 64,724 Common Stock. KENNEDY EDWARD H holds 74,724 shares after the transaction.

  • · Director KENNEDY EDWARD H was awarded 64,724 Common Stock
HUNTINGTON BANCSHARES INC /MD/ 4 positive materiality 5/10

28-10-2026

Director ROLLINS JAMES D III bought 10,000 Dep Shares-int in 5.70% Ser I Non-Cum Perp Pref Stk at $19.43 (~$194K). ROLLINS JAMES D III holds 10,000 shares after the transaction.

  • · Director ROLLINS JAMES D III bought 4,000 Dep Shares-int in 4.50% Ser H Non-Cum Perp Pref Stk at $14.86 (~$59.4K)
  • · Director ROLLINS JAMES D III bought 10,000 Dep Shares-int in 5.70% Ser I Non-Cum Perp Pref Stk at $19.43 (~$194K)
HUNTINGTON BANCSHARES INC /MD/ 4 neutral materiality 3/10

28-10-2026

Director CRANE ANN B was awarded 1,978.174 Common Stock. CRANE ANN B holds 109,356.902 shares after the transaction.

  • · Director CRANE ANN B was awarded 1,978.174 Common Stock
Fulgent Genetics, Inc. 4 neutral materiality 3/10

28-10-2026

Chief Scientific Officer Gao Hanlin had withheld for taxes 1,645 Common Stock at $20.22 (~$33.3K). Gao Hanlin holds 984,472 shares after the transaction.

  • · Chief Scientific Officer Gao Hanlin had withheld for taxes 1,645 Common Stock at $20.22 (~$33.3K)
Fulgent Genetics, Inc. 4 neutral materiality 3/10

28-10-2026

President and COO Xie Jian had withheld for taxes 4,361 Common Stock at $20.22 (~$88.2K). Xie Jian holds 355,563 shares after the transaction.

  • · President and COO Xie Jian had withheld for taxes 4,361 Common Stock at $20.22 (~$88.2K)

Get daily alerts with 12 investment signals, 9 risk alerts, 8 opportunities and full AI analysis of all 50 filings

Start free trial Browse all digests

$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.

More from: USA Insider Trading Pulse

October 20, 2026

USA Insider Trading Pulse — October 20, 2026

October 19, 2026

USA Insider Trading Pulse — October 19, 2026

October 16, 2026

USA Insider Trading Pulse — October 16, 2026

October 15, 2026

USA Insider Trading Pulse — October 15, 2026

🇺🇸 More from United States

View all →

October 21, 2026

US Pre-Market SEC Filings Roundup — October 21, 2026

US Pre-Market SEC Filings Roundup

October 21, 2026

US Merger & Acquisition SEC Filings — October 21, 2026

US Merger & Acquisition SEC Filings

October 20, 2026

US Pre-Market SEC Filings Roundup — October 20, 2026

US Pre-Market SEC Filings Roundup

October 20, 2026

S&P 500 Energy Sector SEC Filings — October 20, 2026

S&P 500 Energy Sector SEC Filings
← All United States digests